(Q44635164)

English

Cerivastatin ameliorates high insulin-enhanced neutrophil–endothelial cell adhesion and endothelial intercellular adhesion molecule-1 expression by inhibiting mitogen-activated protein kinase activation

scientific article published on November 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Cerivastatin ameliorates high insulin-enhanced neutrophil-endothelial cell adhesion and endothelial intercellular adhesion molecule-1 expression by inhibiting mitogen-activated protein kinase activation (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Cerivastatin ameliorates high insulin-enhanced neutrophil–endothelial cell adhesion and endothelial intercellular adhesion molecule-1 expression by inhibiting mitogen-activated protein kinase activation (English)

1 reference

10.1016/S1056-8727(02)00245-3

https://api.crossref.org/works/10.1016/S1056-8727(02)00245-3

26 March 2024

0 references

1 reference

based on heuristic

inferred from title

1 reference

10.1016/S1056-8727(02)00245-3

https://api.crossref.org/works/10.1016/S1056-8727(02)00245-3

26 March 2024

internal medicine

1 reference

10.1016/S1056-8727(02)00245-3

https://api.crossref.org/works/10.1016/S1056-8727(02)00245-3

26 March 2024

author name string

Masahiro Okouchi

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Naotsuka Okayama

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Hitoshi Omi

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Kenro Imaeda

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Manabu Shimizu

5

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Tatsuya Fukutomi

6

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Makoto Itoh

7

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14583185

26 March 2024

publication date

1 November 2003

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S1056872702002453?httpAccept=text/xml

1 reference

10.1016/S1056-8727(02)00245-3

https://api.crossref.org/works/10.1016/S1056-8727(02)00245-3

26 March 2024

https://api.elsevier.com/content/article/PII:S1056872702002453?httpAccept=text/plain

1 reference

10.1016/S1056-8727(02)00245-3

https://api.crossref.org/works/10.1016/S1056-8727(02)00245-3

26 March 2024

Journal of Diabetes and its Complications

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

380-386

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Effects of cerivastatin on human arterial smooth muscle cell proliferation and migration in transfilter cocultures

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900245-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Diabetic dyslipidaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900245-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerivastatin: pharmacology of a novel synthetic and highly active HMG-CoA reductase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900245-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin stimulates mitogen-activated protein kinase by a Ras-independent pathway in 3T3-L1 adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900245-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Direct effects of statins on cells primarily involved in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900245-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-lipid-related effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900245-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Direct effects of statins on the vascular wall

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900245-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Mevalonate-dependent inhibition of transendothelial migration and chemotaxis of human peripheral blood neutrophils by pravastatin

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900245-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Oncogenic Ha-Ras-induced signaling activates NF-kappaB transcriptional activity, which is required for cellular transformation

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900245-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Coronary heart disease in patients with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900245-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900245-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Control of signal transduction and morphogenesis by Ras.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900245-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900245-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A HMG-CoA reductase inhibitor improved regression of atherosclerosis in the rabbit aorta without affecting serum lipid levels: possible relevance of up-regulation of endothelial NO synthase mRNA

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900245-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of fluvastatin on leukocyte-endothelial cell adhesion in hypercholesterolemic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900245-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of the mevalonate pathway: benefits beyond cholesterol reduction?

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900245-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibitory effect of fluvastatin, an HMG-CoA reductase inhibitor, on the expression of adhesion molecules on human monocyte cell line

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900245-3

7 January 2021

based on heuristic

inferred from DOI database lookup

High insulin exacerbates neutrophil-endothelial cell adhesion through endothelial surface expression of intercellular adhesion molecule-1 via activation of protein kinase C and mitogen-activated protein kinase.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900245-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900245-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900245-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: the role of mevalonic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900245-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperinsulinemia and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900245-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A HMG-CoA reductase inhibitor possesses a potent anti-atherosclerotic effect other than serum lipid lowering effects--the relevance of endothelial nitric oxide synthase and superoxide anion scavenging action

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900245-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerivastatin suppresses lipopolysaccharide-induced ICAM-1 expression through inhibition of Rho GTPase in BAEC

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900245-3

7 January 2021

based on heuristic

inferred from DOI database lookup

HMG-CoA reductase inhibitors reduce adhesion of human monocytes to endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900245-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of isoprenoids in vascular smooth muscle: potential benefits of statins unrelated to cholesterol lowering

14

1 reference

10.1016/S1056-8727(02)00245-3

https://api.crossref.org/works/10.1016/S1056-8727(02)00245-3

26 March 2024

Identifiers

10.1016/S1056-8727(02)00245-3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44635164&oldid=2111184846"